Mark Sculpher : Citation Profile


Are you Mark Sculpher?

University of York

10

H index

11

i10 index

389

Citations

RESEARCH PRODUCTION:

32

Articles

19

Papers

2

Books

2

Chapters

RESEARCH ACTIVITY:

   24 years (1994 - 2018). See details.
   Cites by year: 16
   Journals where Mark Sculpher has often published
   Relations with other researchers
   Recent citing documents: 68.    Total self citations: 20 (4.89 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psc810
   Updated: 2018-11-17    RAS profile: 2018-10-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Revill, Paul (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mark Sculpher.

Is cited by:

Brouwer, Werner (12)

Culyer, Anthony (8)

Claxton, Karl (7)

EPSTEIN, DAVID (5)

Towse, Adrian (4)

Karlsberg, Sarah (4)

McCarthy, Ian (4)

Soares, Marta (4)

Stargardt, Tom (3)

LEVAGGI, ROSELLA (3)

Cubi-Molla, Patricia (3)

Cites to:

Claxton, Karl (44)

Brouwer, Werner (15)

Culyer, Anthony (13)

Johannesson, Magnus (13)

Rice, Nigel (13)

McCabe, Christopher (10)

Mullahy, John (9)

Martin, Stephen (7)

Devlin, Nancy (5)

Parkin, David (5)

Gravelle, Hugh (5)

Main data


Where Mark Sculpher has published?


Journals with more than one article published# docs
Health Economics18
PharmacoEconomics9
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York13
Centre for Health Economics and Policy Analysis Working Paper Series / Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada3

Recent works citing Mark Sculpher (2018 and 2017)


YearTitle of citing document
2018When do consumers stand up for the environment? Evidence from a large-scale social experiment to promote environmentally friendly coffee. (2018). Todo, Yasuyuki ; Takahashi, R. In: 2018 Conference, July 28-August 2, 2018, Vancouver, British Columbia. RePEc:ags:iaae18:277507.

Full description at Econpapers || Download paper

2018Setting research priorities in Global Health:Appraising the value of evidence generation activities to support decision-making in health care. (2018). Woods, Beth ; Claxton, Karl ; Phillips, Andrew ; Hallett, Timothy ; Revill, Paul ; Rothery, Claire. In: Working Papers. RePEc:chy:respap:155cherp.

Full description at Econpapers || Download paper

2017Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges. (2017). Hill, Sarah R ; Oluboyede, Yemi ; Henderson, Emily ; Hunter, David ; Vale, Luke . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1249-1262.

Full description at Econpapers || Download paper

2017The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions. (2017). Romley, John ; Lakdawalla, Darius ; Bognar, Katalin ; Chou, Jacquelyn W ; Murray, James ; Bae, Jay P. In: Journal of Health Economics. RePEc:eee:jhecon:v:51:y:2017:i:c:p:1-12.

Full description at Econpapers || Download paper

2017Specialty training for the retention of Malawian doctors: A cost-effectiveness analysis. (2017). Mandeville, Kate L ; Lagarde, Mylene ; Ulaya, Godwin ; Dzowela, Titha ; Muula, Adamson S ; Hanson, Kara. In: Social Science & Medicine. RePEc:eee:socmed:v:194:y:2017:i:c:p:87-95.

Full description at Econpapers || Download paper

2018Health care input constraints and cost effectiveness analysis decision rules. (2018). van Baal, Pieter ; Severens, Johan L ; Morton, Alec. In: Social Science & Medicine. RePEc:eee:socmed:v:200:y:2018:i:c:p:59-64.

Full description at Econpapers || Download paper

2018Life satisfaction, QALYs, and the monetary value of health. (2018). Frijters, Paul ; Clarke, Philip ; Dalziel, Kim ; Huang, LI. In: Social Science & Medicine. RePEc:eee:socmed:v:211:y:2018:i:c:p:131-136.

Full description at Econpapers || Download paper

2018Life satisfaction, QALYs, and the monetary value of health. (2018). Frijters, Paul ; Clarke, Philip ; Dalziel, Kim ; Huang, LI. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:89398.

Full description at Econpapers || Download paper

2018Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review. (2018). Gerdtham, Ulf-G. ; Jarl, Johan ; Minthon, Lennart ; Toresson, Hkan ; Gerdtham, Ulf-G., ; Saha, Sanjib. In: Working Papers. RePEc:hhs:lunewp:2018_010.

Full description at Econpapers || Download paper

2018Competition and Equity in Health Care Markets. (2018). Straume, Odd Rune ; Siciliani, Luigi. In: NIPE Working Papers. RePEc:nip:nipewp:01/2018.

Full description at Econpapers || Download paper

2017Age and Utilities: Issues for HTA. (2017). Shah, Koonal ; Cubi-Molla, Patricia ; Devlin, N ; Herdman, M ; Garside, J. In: Research Papers. RePEc:ohe:respap:001830.

Full description at Econpapers || Download paper

2017Fuzzy approach to decision analysis with multiple criteria and uncertainty in health technology assessment. (2017). Kamiński, Bogumił ; Kamiski, Bogumi ; Jakubczyk, Micha. In: Annals of Operations Research. RePEc:spr:annopr:v:251:y:2017:i:1:d:10.1007_s10479-015-1910-9.

Full description at Econpapers || Download paper

2017Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease. (2017). Sorensen, Sabrina Storgaard ; Ehlers, Lars ; Weinreich, Ulla Moller ; Pedersen, Kjeld Moller . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0298-2.

Full description at Econpapers || Download paper

2017Malaria and Economic Evaluation Methods: Challenges and Opportunities. (2017). Drake, Tom L ; Lubell, Yoel. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0304-8.

Full description at Econpapers || Download paper

2017Aligning Health Economics Methods to Fit with the Changing World of Public Health. (2017). Frew, Emma. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-017-0319-9.

Full description at Econpapers || Download paper

2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?. (2017). Hampson, Grace ; Cole, Amanda ; Devlin, Nancy ; Marsden, Grace ; Cowles, Emma . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:4:d:10.1007_s40258-017-0309-y.

Full description at Econpapers || Download paper

2017We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs. (2017). Mnsdotter, Anna ; Lindholm, Lars ; Hurtig, Anna-Karin ; Hagberg, Lars ; Feldman, Inna ; Ekman, Bjorn . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:4:d:10.1007_s40258-017-0323-0.

Full description at Econpapers || Download paper

2017Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System. (2017). Kim, Dong-jin ; Shin, Jae-Gook ; Oh, Minkyung. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:5:d:10.1007_s40258-017-0317-y.

Full description at Econpapers || Download paper

2017Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort. (2017). Smith, Alexandra ; Patmore, Russell ; Burton, Cathy ; Crouch, Simon ; Roman, Eve ; Aas, Eline. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:2:d:10.1007_s10198-016-0775-4.

Full description at Econpapers || Download paper

2017Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. (2017). Haukaas, Fredrik Salvesen ; Winje, Brita Askeland ; Arnesen, Trude Margrete . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0779-0.

Full description at Econpapers || Download paper

2017Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients. (2017). Burgers, L T ; Severens, J L ; Westwood, M ; Rothery, C ; Walker, S ; Armstrong, N ; Lhachimi, S K ; Redekop, W K. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:6:d:10.1007_s10198-016-0824-z.

Full description at Econpapers || Download paper

2017The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. (2017). Neumann, Anne ; Norstrom, Fredrik ; Klug, Stefanie J ; Schoffer, Olaf ; Norberg, Margareta ; Lindholm, Lars . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:7:d:10.1007_s10198-016-0851-9.

Full description at Econpapers || Download paper

2018New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. (2018). Attema, Arthur ; Exel, Job ; Krol, Marieke . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:2:d:10.1007_s10198-017-0883-9.

Full description at Econpapers || Download paper

2018The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study. (2018). Yang, Wei ; RAATS, MONIQUE ; Jackson, Daniel ; Gage, Heather. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:7:d:10.1007_s10198-017-0934-2.

Full description at Econpapers || Download paper

2018The impact of pre and perinatal lifestyle factors on child long term health and social outcomes: a systematic review. (2018). Bell, Kerry ; Robling, Michael ; Torgerson, David ; Richardson, Gerry ; Ronaldson, Sarah ; Corbacho, Belen . In: Health Economics Review. RePEc:spr:hecrev:v:8:y:2018:i:1:d:10.1186_s13561-018-0186-6.

Full description at Econpapers || Download paper

2017Costs and outcomes of improving population health through better social housing: a cohort study and economic analysis. (2017). Bray, Nathan ; Edwards, Rhiannon Tudor ; Winrow, Eira ; Jones, Alice ; Burns, Paul. In: International Journal of Public Health. RePEc:spr:ijphth:v:62:y:2017:i:9:d:10.1007_s00038-017-0989-y.

Full description at Econpapers || Download paper

2018Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People’s Quality of Life Brief Questionnaire (OPQoL-Brief) Scores. (2018). Kaambwa, Billingsley ; Ratcliffe, Julie. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:1:d:10.1007_s40271-017-0259-3.

Full description at Econpapers || Download paper

2017Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis. (2017). Jutkowitz, Eric ; Jalal, Hawre ; Kuntz, Karen M ; Choi, Hyon K ; Alarid-Escudero, Fernando. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0526-0.

Full description at Econpapers || Download paper

2017Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology. (2017). el Alili, Mohamed ; Bosmans, Judith E ; Tulder, Maurits W ; Judith, ; Dongen, Johanna M. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0531-3.

Full description at Econpapers || Download paper

2017Replicating Health Economic Models: Firm Foundations or a House of Cards?. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0553-x.

Full description at Econpapers || Download paper

2017Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal. (2017). Elliott, Rachel A ; Waring, Justin ; Chuter, Antony ; Latif, Asam ; Boyd, Matthew J ; Mehta, Rajnikant ; Barber, Nick ; Avery, Anthony J ; Gkountouras, Georgios ; Tanajewski, Lukasz. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0554-9.

Full description at Econpapers || Download 2017

The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment. (2017). Grimm, Sabine Elisabeth ; Wailoo, Allan J ; Brennan, Alan ; Strong, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0562-9.

Full description at Econpapers || Download paper

2017Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs). (2017). Chen, Gang ; Maxwell, Aimee ; Iezzi, Angelo ; Ratcliffe, Julie ; Kaambwa, Billingsley ; Richardson, Jeff . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0446-4.

Full description at Econpapers || Download paper

2017Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine. (2017). Paulden, Mike ; Omahony, James F ; McCabe, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0482-0.

Full description at Econpapers || Download paper

2017A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. (2017). Mavranezouli, Ifigeneia ; Lokkerbol, Joran . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0473-1.

Full description at Econpapers || Download paper

2017Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma. (2017). Fust, Kelly ; Lyman, Gary H ; Hoefkens, Caroline ; Somers, Luc ; Weinstein, Milton C ; Barron, Richard ; Parthan, Anju ; Villa, Guillermo ; Maschio, Michael ; Li, Xiaoyan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:4:d:10.1007_s40273-016-0474-0.

Full description at Econpapers || Download 2017

Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15. (2017). Chen, Gang ; Ratcliffe, Julie ; Petersen, Karin Dam ; Stevens, Katherine ; Russo, Remo ; Mpundu-Kaambwa, Christine. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:4:d:10.1007_s40273-016-0476-y.

Full description at Econpapers || Download paper

2017Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study. (2017). Franklin, Matthew ; Julious, Steven ; Kua, Wei Sun ; Horspool, Michelle ; Davis, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-016-0484-y.

Full description at Econpapers || Download paper

2017Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Sys. (2017). Dritsaki, Melina ; Petrou, Stavros ; Mason, James ; Achana, Felix. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-016-0485-x.

Full description at Econpapers || Download paper

2017How Qualitative Methods Can be Used to Inform Model Development. (2017). Husbands, Samantha ; Coast, Joanna ; Barton, Pelham ; Jowett, Susan . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0499-z.

Full description at Econpapers || Download paper

2017Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis. (2017). Shih, Ya-Chen ; Mullins, Daniel C ; Park, Yujin ; Udeze, Chukwukadibia ; Olson, Melvin ; Lecomte, Pascal ; Goto, Daisuke . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0505-5.

Full description at Econpapers || Download paper

2017Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview. (2017). Dasbach, Erik J ; Elbasha, Elamin H. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0508-2.

Full description at Econpapers || Download paper

2017How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis. (2017). Bojke, Laura ; Palmer, Stephen ; Ren, Shijie ; Mahon, Ronan ; Asaria, Miqdad ; Manca, Andrea . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0512-6.

Full description at Econpapers || Download paper

2017Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice Sectors. (2017). Mayer, Susanne ; Silvia, ; Ruwaard, Dirk ; Simon, Judit ; Aszewska, Agata . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0522-4.

Full description at Econpapers || Download paper

2017Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss. (2017). , Ulrikke ; Norheim, Ole F ; Ottersen, Trygve ; Johansson, Kjell A. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0524-2.

Full description at Econpapers || Download paper

2017Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties. (2017). Bojke, Laura ; Stein, Ken ; Soares, Marta ; Peters, Jaime ; Jankovic, Dina ; Grigore, Bogdan . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0525-1.

Full description at Econpapers || Download paper

2018The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal. (2018). McManus, Emma ; Levell, Nick ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:1:d:10.1007_s40273-017-0564-7.

Full description at Econpapers || Download paper

2018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

2018A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis. (2018). Ren, Shijie ; Stevenson, Matt ; Latimer, Nicholas R ; Whyte, Sophie ; Minton, Jonathan . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0584-3.

Full description at Econpapers || Download paper

2018Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis. (2018). Soe, Rebekah Fong ; Alexandre, Leo ; Nelson, Michael Philip ; Hart, Andrew ; Skedgel, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0594-1.

Full description at Econpapers || Download paper

2018Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies. (2018). Makady, Amr ; Goettsch, Wim ; Klungel, Olaf ; Hillege, Hans ; Boer, Anthonius ; Dandon, Anne ; Moseley, Owen ; Jonsson, Pall ; Veelen, Ard. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0596-z.

Full description at Econpapers || Download paper

2018The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA). (2018). Ghabri, Salah ; Josselin, Jean Michel ; Poullie, Anne-Isabelle ; Autin, Erwan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-017-0602-5.

Full description at Econpapers || Download paper

2018Cost Effectiveness of Alectinib vs. Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer. (2018). Carlson, Josh J ; Wong, William ; Orfanos, Panos ; Suh, Kangho. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-018-0625-6.

Full description at Econpapers || Download paper

2018Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. (2018). Wisloff, Torbjorn ; Klovstad, Hilde ; Lovlie, Astrid Louise ; Meijerink, Hinta ; Amundsen, Ellen J ; Dalgard, Olav ; White, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0604-3.

Full description at Econpapers || Download paper

2018Cost-Effectiveness Thresholds: the Past, the Present and the Future. (2018). Thokala, Praveen ; Tong, Thaison ; Leech, Ashley A ; Ochalek, Jessica. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0606-1.

Full description at Econpapers || Download paper

2018Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities. (2018). Keeney, Edna ; Dias, Sofia ; Dawoud, Dalia . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-018-0612-y.

Full description at Econpapers || Download paper

2018The Australian Managed Entry Scheme: Are We Getting it Right?. (2018). Scuffham, Paul ; Tuffaha, Haitham W. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-018-0633-6.

Full description at Econpapers || Download paper

2018Discounting in Economic Evaluations. (2018). Attema, Arthur E ; Claxton, Karl. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z.

Full description at Econpapers || Download paper

2018Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor–positive and Human Epidermal Growth Factor Receptor 2–negative Metastatic Breast Cancer in Japan. (2018). Lertjanyakun, Verin ; Imanaka, Yuichi ; Kunisawa, Susumu ; Chaiyakunapruk, Nathorn. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0660-3.

Full description at Econpapers || Download paper

2018A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values. (2018). Petrou, Stavros ; Madan, Jason ; Kwon, Joseph. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0670-1.

Full description at Econpapers || Download paper

2017The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review. (2017). Adamson, Blythe ; Barnabas, Ruanne ; Devine, Beth ; Dimitrov, Dobromir . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0009-9.

Full description at Econpapers || Download paper

2017Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes. (2017). Terjesen, Christoffer Lilja ; Ehlers, Lars ; Kovaleva, Julia . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0012-9.

Full description at Econpapers || Download paper

2017Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial. (2017). Alshreef, Abualbishr ; Hind, Daniel ; Bradburn, Mike ; Biggs, Katie ; Tiernan, James P ; Brown, Steven R ; Wailoo, Allan J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0023-6.

Full description at Econpapers || Download paper

2017Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review. (2017). Burn, Edward ; Pinedo-Villanueva, Rafael ; Murray, David W ; Pandit, Hemant G ; Pai, Sunil ; Hamilton, Thomas W ; Liddle, Alexander D. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0017-4.

Full description at Econpapers || Download paper

2018The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5.

Full description at Econpapers || Download paper

2018Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis. (2018). Michaud, Tzeyu L ; Kuntz, Karen M ; Nyman, John A ; Gaugler, Joseph E ; McCarten, Riley J ; Kane, Robert L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0054-z.

Full description at Econpapers || Download paper

2017The effects of physical activity on social interactions: The case of trust and trustworthiness. (2017). Papa, Stefano ; Di Bartolomeo, Giovanni. In: wp.comunite. RePEc:ter:wpaper:00134.

Full description at Econpapers || Download paper

2017Management of knee osteoarthritis in Italy. A cost-utility analysis of Platelet-Rich-Plasma dedicated kit versus Hyaluronic acid for the intra-articular treatment of knee OA.. (2017). Landi, Stefano ; Russo, Salvatore ; Landa, Paolo . In: Working Papers. RePEc:vnm:wpdman:141.

Full description at Econpapers || Download paper

Works by Mark Sculpher:


YearTitleTypeCited
2015Country-level cost-effectiveness thresholds: initial estimates and the need for further research In: Working Papers.
[Full Text][Citation analysis]
paper8
2016Supporting the development of an essential health package: principles and initial assessment for Malawi In: Working Papers.
[Full Text][Citation analysis]
paper1
2017Scoping review on social care economic evaluation methods In: Working Papers.
[Full Text][Citation analysis]
paper0
1999A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis In: Working Papers.
[Full Text][Citation analysis]
paper0
2000Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling In: Working Papers.
[Full Text][Citation analysis]
paper6
2007Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions In: Working Papers.
[Full Text][Citation analysis]
paper3
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]
paper17
2005The value of implementation and the value of information: combined and uneven development In: Working Papers.
[Full Text][Citation analysis]
paper2
2011Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS In: Working Papers.
[Full Text][Citation analysis]
paper4
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]
paper4
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]
paper25
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]
paper4
2006Defining and characterising structural uncertainty in decision analytic models In: Working Papers.
[Full Text][Citation analysis]
paper3
2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations In: Health Policy.
[Full Text][Citation analysis]
article11
2002Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions In: Social Science & Medicine.
[Full Text][Citation analysis]
article1
2012Decision-making with Uncertainty: The Value of Information In: Chapters.
[Full Text][Citation analysis]
chapter0
2006Decision-making with Uncertainty: The Value of Information.(2006) In: Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
chapter
1999Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
2010Understanding Harris’ understanding of CEA: is cost effective resource allocation undone? In: Working Papers.
[Full Text][Citation analysis]
paper0
2000Productivity Costs: Principles and Practice in Economic Evaluation In: Monographs.
[Full Text][Citation analysis]
book7
2006Decision Modelling for Health Economic Evaluation In: OUP Catalogue.
[Citation analysis]
book102
2014What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2005Estimating utility data from clinical indicators for patients with stable angina In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2000Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2006Assessing Generalisability in Model-Based Economic Evaluation Studies In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2007A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2007Recombinant Erythropoietin for Chemotherapy-Related Anaemia In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2012Real Economics Needs to Reflect Real Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2013Acknowledging Patient Heterogeneity in Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2016Should the Lambda (λ) Remain Silent? In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2016Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2001Recognizing diversity in public preferences: The use of preference sub-groups in cost-effectiveness analysis In: Health Economics.
[Full Text][Citation analysis]
article10
2001Representing uncertainty: the role of cost-effectiveness acceptability curves In: Health Economics.
[Full Text][Citation analysis]
article47
2002Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Authors reply In: Health Economics.
[Full Text][Citation analysis]
article0
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]
article25
2005Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models In: Health Economics.
[Full Text][Citation analysis]
article12
2005Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility In: Health Economics.
[Full Text][Citation analysis]
article20
2006Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion In: Health Economics.
[Full Text][Citation analysis]
article13
2006Evidence synthesis, parameter correlation and probabilistic sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]
article3
2006Whither trial-based economic evaluation for health care decision making? In: Health Economics.
[Full Text][Citation analysis]
article26
2010Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods In: Health Economics.
[Full Text][Citation analysis]
article1
2011Dangerous omissions: the consequences of ignoring decision uncertainty In: Health Economics.
[Full Text][Citation analysis]
article7
2015CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? In: Health Economics.
[Full Text][Citation analysis]
article7
2017Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs In: Health Economics.
[Full Text][Citation analysis]
article0
2018Social value and individual choice: The value of a choice†based decision†making process in a collectively funded health system In: Health Economics.
[Full Text][Citation analysis]
article0
2018How to design the cost†effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework In: Health Economics.
[Full Text][Citation analysis]
article0
1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]
article7
1995Sensitivity analysis in economic evaluation: A review of published studies In: Health Economics.
[Citation analysis]
article5
1998The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia In: Health Economics.
[Citation analysis]
article1
1995Economic Evaluation in Health Care Research and Development: Undertake it Early and Often In: Discussion Papers.
[Full Text][Citation analysis]
paper0
1996Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation In: Discussion Papers.
[Full Text][Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 2th 2018. Contact: CitEc Team